R. A. Harrington Et Al. , "The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale," AMERICAN HEART JOURNAL , vol.158, no.3, pp.327-338, 2009
Harrington, R. A. Et Al. 2009. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale. AMERICAN HEART JOURNAL , vol.158, no.3 , 327-338.
Harrington, R. A., Van de Werf, F., Armstrong, P. W., Aylward, P., Veltri, E., Mahaffey, K. W., ... Moliterno, D. J.(2009). The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale. AMERICAN HEART JOURNAL , vol.158, no.3, 327-338.
Harrington, Robert Et Al. "The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale," AMERICAN HEART JOURNAL , vol.158, no.3, 327-338, 2009
Harrington, Robert A. Et Al. "The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale." AMERICAN HEART JOURNAL , vol.158, no.3, pp.327-338, 2009
Harrington, R. A. Et Al. (2009) . "The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale." AMERICAN HEART JOURNAL , vol.158, no.3, pp.327-338.
@article{article, author={Robert A. Harrington Et Al. }, title={The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale}, journal={AMERICAN HEART JOURNAL}, year=2009, pages={327-338} }